K960871

Substantially Equivalent

SPECTROLYSE ANTITHROMBIN III (ANTI-XA)

Applicant: Medical Diagnostic Technologies, Inc.
Product code: JBQ
Advisory panel: Hematology
Date received: 1996-03-04
Decision date: 1996-08-14
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Ventura, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.